Full-Time

Senior Vice President

Clinical Development Operations

Posted on 9/24/2024

Relay Therapeutics

Relay Therapeutics

201-500 employees

Biotech company focused on drug discovery

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • 15+ years of experience in the biopharma or CRO industry with thorough understanding of clinical trial processes including clinical project management, clinical supply, data management, and medical writing
  • Recognized as a clinical development operations leader with a prior track record of success and history of innovative program and trial execution that utilizes the latest technologies to facilitate study execution, accelerate timelines, maintain data integrity, and satisfy health authority requirements
  • Domain expertise in oncology drug development is must, including experience in executing early and late-stage clinical trials in oncology
  • Strong and current knowledge in Good Clinical Practices and ICH Guidelines and the application to the conduct of clinical trials
  • Successful experience from a previous fast-paced entrepreneurial biotechnology environment
  • Ability to display strategic planning, attention to detail, and an analytical approach to problem solving
  • Leader who communicates and demonstrates vision and commitment
  • Eager and able to mentor and develop talent in the organization
  • Strong influencing skills
Responsibilities
  • Provide strategic leadership for Clinical Development Operations presenting a strong, clear voice both internally and externally, to deliver high-quality results for all Relay Tx sponsored clinical studies across the product lifecycle
  • Partner with internal stakeholders to integrate clinical operations knowledge and expertise into all applicable clinical development activities, including product development plans, study protocols, and patient finding and recruitment strategies
  • Lead and retain a world-class operations team by attracting and developing talent to grow into roles of increasing scope and seniority and maintaining a culture of engagement and drive
  • Build and maintain strong relationships with internal and external partners such as the broader Development organization, Finance, Legal, and Contract Research Organizations (CROs)
  • Ability to provide strategic direction in clinical trial design for Phase 1- Phase 3 trials
  • Ability to be forward-thinking and innovative in terms of how to scale organizations

Relay Therapeutics focuses on drug discovery by emphasizing the movement of proteins in its research. The company uses its Dynamo™ platform, which integrates experimental and computational methods, to identify and develop new drugs, particularly for complex diseases that are hard to treat with current therapies. This platform enables Relay to target proteins that have previously been difficult to address, expanding treatment options in areas like precision oncology and genetic diseases. Unlike many competitors, Relay Therapeutics collaborates with major biotech firms, such as Genentech, to validate its technology and generate revenue through licensing and partnerships. The main goal of Relay Therapeutics is to create impactful medicines for patients, and it is actively conducting clinical trials to ensure the safety and effectiveness of its drug candidates.

Company Stage

IPO

Total Funding

$535M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

-10%

1 year growth

-17%

2 year growth

-13%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing market for AI-driven drug discovery supports Relay's platform.
  • Precision medicine trend aligns with Relay's focus on personalized treatments.
  • Favorable regulatory environment for AI-developed drugs benefits Relay's approach.

What critics are saying

  • Increased competition from companies like VantAI threatens Relay's market position.
  • Recent workforce layoffs may impact operational efficiency and morale.
  • Departure of key personnel could affect expertise and continuity in drug discovery.

What makes Relay Therapeutics unique

  • Relay's Dynamo platform targets previously undruggable proteins, expanding treatment possibilities.
  • Focus on precision oncology allows for personalized cancer treatments.
  • Combines computational and experimental techniques for innovative drug discovery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, vision

Life, disability, & FSA

401k

Commuter benefits

Parental leave

Home office stipend

Tuition reimbursement

PTO

INACTIVE